FOLFIRI
Leucovorin, 5-Fluorouracil, Irinotecan · Colorectal & Gastrointestinal Regimen
Indications & Uses
First-line and second-line therapy for Metastatic Colorectal Cancer, Gastric Cancer, and Esophageal Adenocarcinoma.
Contraindications
Known homozygous DPD deficiency, severe active inflammatory bowel disease.
Side Effects & Warnings
Early and late diarrhea, cholinergic syndrome, neutropenia, mucositis, fatigue.
Drug & Dietary Interactions
Extensive interactions; consult specific multi-agent administration and hydration protocols.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.